A standardized, batch-normalized flow cytometry assay enables practical phenotypic screening of CBB inventories for reduced CCR5 expression and enriches for both CCR5Δ32 and diverse non-Δ32 variants. This phenotype-first strategy may complement targeted genotyping by identifying candidate HIV-resistant CBUs missed by Δ32-focused approaches.
Simard et al. (2026) studied this question.